OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)

• NASDAQ: $OPK
• Notified: $5.08
• 14:45 EDT